HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer

Clinical trial NCT03578406 · COMPLETED

Trial details

NCT number: NCT03578406
Sponsor: Xinqiao Hospital of Chongqing
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2018-09-01
Primary completion: 2022-04-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.